EPCAM and ovarian cancer: For example, a nanoplasmonic exosome (nPLEX) assay was developed based on transmission surface plasmon resonance (SPR) and arrays of periodic nanoholes functionalized with antibodies to identify exosomal CD24 and EpCAM expression in ascites fluid from ovarian cancer patients 13.